More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is a highly contagious member of the herpes virus family, best known for causing infectious ...
Rep. Rosa DeLauro warned that limiting grants from the National Institutes of Health will cause “irreparable damage.” ...
Two decades after “The Republican War on Science” was published, the broader crisis has reached a level that hardly seemed possible in the recent past.
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...
EST NLS Pharmaceutics (NLSP) files $75M mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...
Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 ...
A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...
In the coming years, an unprecedented number of people will leave planet Earth—but it’s becoming increasingly clear that deep ...
ZURICH and NESS ZIONA, Israel - NLS Pharmaceutics Ltd. (Nasdaq: NLSP) and Kadimastem Ltd. (TASE: KDST) announced plans for a merger, aiming to enhance diabetes treatment by combining their expertise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results